CymaBay Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
31,244.00
34,795.00
41,480.00
16,994.00
97,210.00
178,664
Total Accounts Receivable
178.00
347.00
186.00
-
5,000.00
-
Other Current Assets
817.00
2,087.00
1,128.00
1,534.00
1,334.00
2,898
Total Current Assets
32,239.00
37,229.00
42,794.00
18,528.00
103,544.00
181,562
Net Property, Plant & Equipment
3.00
86.00
64.00
77.00
69.00
2,905
Total Investments and Advances
155.00
100.00
170.00
170.00
-
-
Other Assets
103.00
59.00
51.00
584.00
634.00
2,280
Total Assets
32,500.00
37,474.00
43,079.00
19,359.00
104,247.00
186,747
ST Debt & Current Portion LT Debt
38.00
1,355.00
509.00
2,700.00
3,108.00
Accounts Payable
697.00
-
-
899.00
1,311.00
Other Current Liabilities
8,753.00
19,104.00
5,637.00
5,712.00
11,891.00
Total Current Liabilities
9,488.00
20,459.00
6,146.00
9,311.00
16,310.00
Long-Term Debt
4,407.00
3,152.00
8,799.00
6,098.00
2,990.00
Other Liabilities
9.00
13.00
19.00
13.00
-
Total Liabilities
13,904.00
23,624.00
14,964.00
15,422.00
19,300.00
Common Equity (Total)
18,596.00
13,850.00
28,115.00
3,937.00
84,947.00
Total Shareholders' Equity
18,596.00
13,850.00
28,115.00
3,937.00
84,947.00
Total Equity
18,596.00
13,850.00
28,115.00
3,937.00
84,947.00
Liabilities & Shareholders' Equity
32,500.00
37,474.00
43,079.00
19,359.00
104,247.00
About CymaBay Therapeutics
View Profile
